] of cultured VSM cells (A7r5 cell line) using whole cell voltage clamp. The cells were exposed to each disrupter for 1 h and then examined electrophysiologically and morphologically. Results of immunostaining using anti-␣-actin and anti-␣-tubulin antibodies showed that colchicine disrupted both actin filaments and microtubules, cytochalasin D disrupted only actin filaments, and nocodazole disrupted only microtubules. I Ba(L) was greatly reduced in cells that were exposed to colchicine or cytochalasin D but not to nocodazole. Colchicine even inhibited I Ba(L) by about 40% when the actin filaments were stabilized by phalloidin or when the cells were treated with phalloidin plus taxol to stabilize both cytoskeletal components. These results suggest that colchicine must also cause some inhibition of I Ba(L) due to another unknown mechanism, e.g., a direct block of Ca L channels. In summary, actin filament disruption of VSM cells inhibits Ca L channel activity, whereas disrupting the microtubules does not.
response to extracellular stimuli have been extensively studied and are the subject of several recent reviews (13, 30, 39) .
The influence of cytoskeletal structures on signaling in vivo is often detected by the effects of specific agents, such as cytochalasin, nocodazole, or acrylamide, that selectively disrupt actin filaments, microtubules, and IFs, respectively. Ion channels and other ion transport molecules (e.g., Na ϩ -K ϩ pump and Na ϩ /Ca 2ϩ exchanger) are integral to the plasma membrane and are attached to cytoskeletal strands, in particular actin filaments (12, 24) . Actin accounts for Ͼ20% of the total cell proteins, and actin and actin-binding proteins couple to several ion channels and ion transport molecules (4) . Intracellular Ca 2ϩ is known to play an important role in regulating cell morphology. Early studies showed the Ca 2ϩ sensitivity of actin and actin-binding proteins, which are major cytoskeletal components (20, 33) . Moreover, Ca 2ϩ ions regulate the formation of actin bundles and networks (3, 36) .
Fukuda et al. (7) obtained indirect evidence that the cytoskeleton may regulate Ca 2ϩ channel kinetics. They showed that colchicine caused a reduction of the upstroke velocity of action potentials, and they inferred that Ca 2ϩ channels interact with the cytoskeleton. Johnson and Byerly (14) have provided direct evidence that microtubules are implicated in the inactivation of snail neuron Ca 2ϩ currents. These authors reported that cytoskeletal disrupters and stabilizers affect the rundown of Ca 2ϩ (Ca L ) channels. Galli and DeFelice (8) reported that colchicine and taxol strongly influence the kinetics of L-type Ca 2ϩ channels in intact cardiac cells through their action on the cytoskeleton, which, in turn, might regulate the effective concentration of inactivating ions near the channel mouth. It is not clear whether the actin filaments and/or microtubules are involved in this regulation.
We investigated several of the cytoskeletal regulatory mechanisms for Ca L channels in a cultured vascular smooth muscle (VSM) cell line (A7r5) derived from rat aorta. The relationship between the cytoskel-eton and Ca L channel activity has not been clearly defined for VSM cells. To clarify the interactions between the cytoskeleton and Ca L channel activity, we used specific disrupters of different components of the cytoskeleton, namely, cytochalasin D for the actin microfilaments, nocodazole for the microtubules, and colchicine for both components. We confirmed the disruption by immunofluorescence staining. The effects of disruption of actin filaments and microtubules on the Ca L channel current of cultured VSM cells (A7r5 cell line) were measured using the whole cell voltage clamp. We found that disruption of the actin filaments inhibited activity of the Ca L channels, whereas microtubule disruption had no effect.
MATERIALS AND METHODS
Cell culture. A7r5 cells were purchased from American Type Culture Collection (Rockville, MD) and maintained as previously reported (28) under 5% CO 2 at 37°C in DMEM (Life Technologies, Grand Island, NY) containing 10% fetal bovine serum (HyClone Laboratories, Logan, UT), 100 U/ml penicillin G, and 100 mg/ml streptomycin sulfate (Life Technologies). After cells were grown to confluence, the cells were trypsinized by treatment for 5 min with 0.05% trypsin (Clonetics, San Diego, CA), plated on microscope glass coverslips (Fisher Scientific, Pittsburgh, PA) coated with poly-L-lysine (Sigma Chemical, St. Louis, MO), and then grown again to confluency. On the day of each experiment, the cells on coverslips were trypsinized for 1 min to isolate the cells and were then incubated for 30 min in serum-free DMEM (SFM) at CO 2 incubator. To study the effect of various disrupters (colchicine, cytochalasin D, nocodazole, and the mixture of nocodazole with cytochalasin D), the cells were exposed to SFM containing each drug for 1 h at 37°C. To study the effect of the cytoskeleton stabilizers (phalloidin, taxol), the cells were exposed to SFM containing each drug for 30 min at 37°C. These cells were then exposed to SFM containing cytoskeleton disrupters (plus the stabilizer) for 1 h at 37°C. For immunostaining of cytoskeleton, the cells were fixed immediately after they were rinsed with phosphate-buffered saline (PBS). For electrophysiological study, the cells were kept under 5% CO 2 at 37°C in SFM until the start of measuring Ca L channel current by whole cell voltage clamp (usually between 1 and 2 h after treatment). That is, all current measurements were made after washout of all drugs. Cells examined by immunostaining 0.5-2 h after wash out of the cytoskeletal disrupters showed continued marked disruption of the cytoskeletal components. Therefore, we completed our electrical measurements within 2 h. The drugs were removed to circumvent the possibility that the drugs might have a direct effect on the ion channels.
Immunofluorescence study. For immunofluorescence study, the cells were incubated in the absence (control) or presence of each disrupter (colchicine, cytochalasin D, nocodazole, or the mixture of nocodazole with cytochalasin D) in SFM for 1 h in CO 2 incubator at 37°C. Control cells were incubated in the presence of 0.1% DMSO (final concentration) in SFM. After incubation, the cells were washed with PBS containing 1 mM EGTA (PBS-EGTA). The cells were washed three times with PBS-EGTA at every step in this immunofluorescence experiment. The cells were fixed for 30 min with 10% Formalin and permeabilized with 0.5% Triton X-100 in PBS-EGTA. The cells were incubated with blocking solution (20% normal goat serum in PBS-EGTA) for 30 min at room temperature. To detect actin filaments and microtubules, monoclonal antibody against smooth muscle anti-␣-actin (Sigma) and anti ␣-tubulin (Sigma) was used as a primary antibody, respectively. The cells were reacted with primary antibody for 30 min and reacted with FITC-conjugated goat anti-mouse IgG (Sigma) for 30 min in a dark room. After the cells were mounted on the microscope slides with Gel/Mount (Biomed), the cells were visualized using a fluorescent microscope.
Electrophysiological study. Whole cell voltage-clamp recordings were made by using a patch-clamp amplifier (Axopatch-1D; Axon Instruments, Foster City, CA) according to the standard techniques. All experiments were performed at room temperature (20-22°C). The recording electrodes (resistance of 2-5 ⍀M) were made from borosilicate glass capillary tubing by using a two-stage puller. Coverslips with attached cells were placed in a small chamber on an inverted microscope (Diaphoto-TMD; Nikon, Tokyo, Japan).
After gigaohm seal (Ͼ5 G⍀) was made, the patch membrane was disrupted by further negative pressure to obtain the whole cell configuration. Voltage commands were given to elicit Ca 2ϩ channel currents, and leak current and residual capacitative current were subtracted by using P/4 protocol (37). Membrane currents were filtered at 1.0 kHz and sampled at 2.5 kHz. The storing and analysis of the digitized signals were carried out by using the pCLAMP software (version 5.05, Axon Instruments). The membrane capacitance was measured from the current amplitude elicited in response to hyperpolarizing voltage ramp pulse of 0.2 V/s from a holding potential of 0 mV (25 ms duration; peak amplitude of Ϫ5 mV) to avoid interference by any timedependent ionic current (37) . Average cell-membrane capacitance was 50.7 Ϯ 5.86 pF (n ϭ 107 ).
Experimental solutions. Seal formation was accomplished in a bath solution having the following composition (in mM): 140 NaCl, 6 KCl, 2.5 MgCl 2 , 10 glucose, and 10 HEPES; the pH was adjusted to 7.4 with Tris. To isolate the Ca 2ϩ channel current in the whole cell configuration, the bath solution was changed to the following Na ϩ -and K ϩ -free solution (in mM): 140 tetraethylammonium (TEA)-Cl, 5 BaCl 2 , 1 MgCl 2 , 11 glucose, 10 HEPES, and 5 4-aminopyridine; pH was adjusted to 7.4 with TEA-OH. The pipette solution consisted of (in mM) 100 CsOH, 30 CsCl, 1 MgCl 2 , 10 EGTA, 10 HEPES, 112 L-glutamate, and 5 ATP⅐Na 2 ; pH was adjusted to pH 7.2 with CsOH.
Drugs and reagents. Colchicine, cytochalasin D, nocodazole, phalloidin, and taxol were purchased from Sigma Chemical. The stock solutions of the disrupters and stabilizers, which were dissolved in DMSO, were stored at Ϫ20°C. The final concentration of DMSO to which the cells were exposed was 0.01% (0.1% at 100 M cytochalasin D); this concentration by itself was shown to have no significant effect on I Ba(L) in 10 cells tested.
Data analysis. All data are given as means Ϯ SE. Statistical analyses were performed by Student's unpaired t-test and one-way ANOVA, followed by Dunnett's multiple comparison by using the software of StatView (version 4.5; Abacus Concepts, Berkeley, CA). A value of P Ͻ 0.01 was taken to be statistically significant.
RESULTS
Disruption of actin filaments and microtubules produced by the various cytoskeletal disrupters was confirmed by immunofluorescence staining using specific antibodies to ␣-actin and ␣-tubulin. In control cells treated with 1% DMSO (the solvent), a dense array of actin filaments (top left) and a fine mesh of microtu- (Fig. 1B) . Cytochalasin D (100 M) produced prominent changes in the actin filaments; however, the fine mesh of microtubules similar to that in control remained (Fig. 1C) . These results showed that colchicine (100 M) disrupted both actin filaments and microtubules, whereas cytochalasin D (100 M) only disrupted actin filaments.
To test the effect of disruption of cytoskeleton on the Ca L channel activity, I Ba(L) was measured 1 h after treatment with the various cytoskeleton disrupters in A7r5 cells. After the cells were exposed to the different concentrations of colchicine (1-100 M) for 1 h, the I Ba(L) was measured under the conditions of 130 mM Cs ϩ in the pipette solution and 5 mM Ba 2ϩ in the bath solution. To obtain current-voltage relationships (I-V), I Ba(L) was elicited every 15 s by various test potentials (Ϫ30 to ϩ60 mV, 10-mV increments, 300-ms duration from a holding potential of Ϫ40 mV). The control I-V relationship had a maximal amplitude of Ϫ7.88 Ϯ 0.78 pA/pF at a test potential of ϩ10 mV. The peak amplitude of I Ba(L) was inhibited by colchicine in a dosedependent manner: 1 M, Ϫ5.95 Ϯ 0.73 pA/pF; 10 M, Ϫ4.5 Ϯ 0.37 pA/pF; and 100 M, Ϫ2.62 Ϯ 0.3 pA/pF (Fig. 2) . Because the reversal potentials of colchicinetreated cells were all near to 60 mV, colchicine inhibition of I Ba(L) was not due to stimulation of an outward current (e.g., I Cl ). The results of immunostaining of cytoskeleton showed that 10 M colchicine also disrupted both actin filaments and microtubules, whereas 1 M colchicine disrupted microtubules but not actin filaments (data not shown). Therefore, Ca L channel activity was inhibited by colchicine most likely through either disruption of actin filaments or microtubules (Fig. 2) .
Because we found that colchicine actually disrupted both actin filaments and microtubules at higher concentrations than 1 M, a specific actin filament disrupter, cytochalasin D, was used to test the effect of disruption of actin filaments on the Ca L channel activity. The I-V relationships were obtained from the cells without the drug (control) or after exposure to 100 M cytochalasin D. In control, maximal peak amplitude was Ϫ8.21 Ϯ 0.47 pA/pF at ϩ10 mV of a test potential. The peak amplitude of I Ba(L) was inhibited to Ϫ2.99 Ϯ 0.3 pA/pF by 100 M cytochalasin D (Fig. 3) . As shown in Fig. 1B , only actin filaments were completely disrupted by 100 M cytochalasin D. Therefore, Ca L channel activity was inhibited by cytochalasin D likely due to disruption of actin filaments.
To compare the degree of inhibition of Ca L channel activity by colchicine and cytochalasin D, various concentrations of these drugs were tested. Figure 4 shows the concentration-response relations for the inhibitory effect of these drugs on I Ba(L) . The inhibition of I Ba(L) produced by 10 and 100 M cytochalasin D was statistically significant compared with control (P Ͻ 0.01 by one-way ANOVA): 10 M, Ϫ5.9 Ϯ 0.4 pA/pF (n ϭ 14); and 100 M, Ϫ4.9 Ϯ 0.6 pA/pF (n ϭ 10). The inhibition of I Ba(L) produced by 10 and 100 M colchicine was also statistically significant compared with control (P Ͻ . Current-voltage (I-V) relationships were obtained for control (E, n ϭ 21) and after exposure to colchicine at 1 M (s, n ϭ 14), 10 M (OE, n ϭ 14), and 100 M (F, n ϭ 12). Data are expressed as means Ϯ SE. As can be seen, the voltage for maximum current was ϩ10 mV. Inset: current traces for control and after application of colchicine (100 M). Cell capacitances were 59 pA (control cell) and 60 pA (colchicine-treated cell). E m , membrane potential. 0.01 by one-way ANOVA): 10 M, Ϫ4.5 Ϯ 0.4 pA/pF (n ϭ 14); and 100 M, Ϫ2.6 Ϯ 0.3 pA/pF (n ϭ 12). As can be seen in Fig. 4 , colchicine inhibition of I Ba(L) was more potent than that produced by cytochalasin D.
We examined whether colchicine and cytochalasin D affected the inactivation of Ca 2ϩ current. The time constants () for colchicine (100 M) and cytochalasin D (100 M) were not statistically significant compared with control (P ϭ 0.146 by one-way ANOVA; Table 1 ). Therefore, colchicine and cytochalasin D did not affect the decay of Ca L channel current.
The actin filament stabilizer phalloidin was used to further verify the involvement of actin filaments in the inhibition of the Ca L channel activity produced by cytochalasin D or colchicine. The peak amplitude of I Ba(L) (at ϩ10-20 mV) was (in pA/pF) phalloidin, Ϫ7.18 Ϯ 0.64 (n ϭ 10); phalloidin plus cytochalasin D, Ϫ7.03 Ϯ 0.69 (n ϭ 8); and phalloidin plus colchicine, Ϫ4.24 Ϯ 0.64 (n ϭ 8) (Fig. 5, Table 2 ). Therefore, the cytochalasin D inhibition of I Ba(L) was completely prevented by phalloidin, whereas the larger colchicine inhibition was only partially prevented (Fig. 5 , Table  2 ). Immunostaining showed that the actin filaments were not disrupted by cytochalasin D or by colchicine in the presence of phalloidin.
To test the possible involvement of microtubules in the excess inhibition of I Ba(L) produced by colchicine, a combination of phalloidin and taxol was used to stabilize both components of the cytoskeleton. As can be seen in Table 2 and Fig. 6 , I Ba(L) was inhibited (by ϳ36%) by colchicine even when the cytoskeleton was completely stabilized. Therefore, colchicine must exert an effect on the Ca L channels that is independent of the cytoskeleton. Colchicine also failed to disrupt either cytoskeletal component when the cells were treated with phalloidin plus taxol.
Because colchicine disrupted both actin filaments and microtubules (as shown in Fig. 1) , it was expected that the difference in inhibition of I Ba(L) between colchicine and cytochalasin D occurred due to the disruption of microtubules. To test this hypothesis, a specific microtubule disrupter, nocodazole, was used. Immunostaining of cytoskeleton after exposure to 1.3 M nocodazole demonstrates that a dense array of actin filaments can be seen in similar structure to that in control (Fig. 7A, left) . There was diffuse fluorescence in the cytoplasma when anti-␣-tubulin was used (Fig. 7A,  right) . Therefore, nocodazole disrupted microtubules, but not actin filaments, even when the concentration was increased to 10 M (data not shown). The I-V relationships were obtained from the cells without the drug (control) or after exposure to 1.3 M nocodazole. In control, maximal peak amplitude was Ϫ7.68 Ϯ 0.78 pA/pF at ϩ10 mV of a test potential. The peak amplitude of I Ba(L) was not inhibited by nocodazole (Fig. 7B) .
Although both actin filaments and microtubules were disrupted after exposure to the mixture of 10 M nocodazole and 10 M cytochalasin D (data not shown), there was no further inhibition of I Ba(L) compared with inhibition produced by cytochalasin D alone (Table 1) . Therefore, the difference in inhibition of I Ba(L) between colchicine and cytochalasin D may not be due to the disruption of microtubules.
DISCUSSION
We investigated the effects of disruption of actin filaments and microtubules on the L-type Ca 2ϩ current [I Ba(L) ] of cultured VSM cells (A7r5 cell line) using whole cell voltage clamp. Immunostaining was used to confirm the degree of disruption. Colchicine disrupted both actin filaments and microtubules (at concentrations Ͼ1 M), whereas cytochalasin D disrupted only actin filaments (even when the concentration was increased up to 100 M). I Ba(L) was greatly reduced in cells that were exposed to 100 M colchicine or cytochalasin D. In the presence of phalloidin, cytochalasin D (100 M) did not disrupt actin filaments and did not inhibit I Ba(L) . Phalloidin alone, which stabilizes actin filaments, did not affect I Ba(L) . Nocodazole, which only disrupted microtubules, did not affect I Ba(L) . Therefore, only disruption of actin filaments produced inhibition of Ca L channel activity.
Interactions between various ion channel proteins and the cytoskeleton have been implicated in mediating spatial localization of channel proteins and in the regulation of ion channel activity (9, 25) . For example, Galli and DeFelice (8) reported that colchicine strongly influences the kinetics of L-type Ca 2ϩ channels in intact cardiac cells. They reported that colchicine (80 M, ] i ) response to high-K ϩ depolarization of neuronal cells was increased by colchicine, and the increase was abolished by nifedipine. Therefore, they concluded that disruption of the cytoskeleton stimulated the activity of the Ca L channels. These results are opposite to what we have found for VSM cells. However, because they did not measure the Ca L channel activity, it is not clear whether their observed increase in [Ca 2ϩ ] i produced by colchicine was due to stimulation of Ca L channel activity. If stimulation of Ca L channel activity did occur with colchicine, it could have resulted from stimulation via the cAMP/cAMP-dependent protein kinase (PKA) pathway [because the cytoskeleton affects adenylate cyclase (A-cyclase) activity]. Also, it was reported (32) that disruption of the microtubules (by colchicine or oryzalin) caused a very large increase in voltagedependent Ca 2ϩ channel activity (and half-life) of carrot cells, whereas the microtubule stabilizer taxol had no effect.
Although ) and a Ca 2ϩ -free ] i should not occur under these conditions. Therefore, the decrease in I Ca(L) we found upon actin-filament disruption cannot be explained by Ca 2ϩ inhibition of Ca 2ϩ channels. In addition, colchicine and cytochalasin D did not affect the voltage-dependent inactivation of Ca L channel current.
The tyrosine kinase inhibitor genistein was found to inhibit basal I Ca(L) in whole cell voltage clamp of rat ventricular cells (38) and to significantly inhibit singlechannel activity in rat portal vein VSM cells (15) . A nonreceptor tyrosine protein kinase (Tyr-PK), pp60 cSrc, was reported to stimulate Ca 2ϩ channel currents in rabbit ear artery VSM cells (34) . These results suggest that Ca 2ϩ channels are modulated (stimulated) by phosphorylation with Tyr-PK. Some nonreceptor TyrPKs that are bound to the cytoplasmic face of the plasma membrane may play a role in signaling (22) . pp60 c-Src was the first protein kinase found to translocate to the cytoskeleton after its activation. The actin filaments are involved in this translocation (5) . c-Src moves from the cytosol to the cytoskeleton near the cell membrane when cells are infected with a virus, and the actin-binding protein vinculin is involved (1) . In addition, translocation of c-Src to the cytoskeleton of A-172 glioblastoma cells is induced by both platelet-derived growth factor and epidermal growth factor in a process that also activates tyrosine kinase activity (18) . Stimulation of platelets by thrombin also translocates c-Src to the actin cytoskeleton (10) . In fibroblasts, translocation of c-Src to near the cell membrane could be blocked by cytochalasin D, but not by nocodazole (5) . These results suggest that disruption of actin filaments releases the nonreceptor Tyr-PK (c-Src) from the cytoplasmic face of the plasma membrane into the cytoplasm. As a result of this translocation, the nonreceptor Tyr-PK would not be able to activate the Ca L channel by phosphorylation. Therefore, Ca L channel activity would be inhibited by disruption of actin filaments.
Although 1 M colchicine dose not disrupt actin filaments, this low dose reduced Ca L channel activity (see Fig. 2 ). In addition, colchicine inhibited I Ba(L) by 40% when actin filaments were stabilized by phalloidin. Colchicine still inhibited I Ba(L) by 36% even when the cells were treated with phalloidin plus taxol to stabilize both cytoskeletal components (see Table 2 ). These results suggest that colchicine must also cause some inhibition of I Ba(L) due to another unknown mechanism e.g., a direct block of Ca L channels. That is, in addition to the disruption of the actin cytoskeleton and resultant partial inhibition of the activity of the Ca L channels, because colchicine produced stronger inhibition of Ca L channel activity than did cytochalasin D (see Fig. 4 ), colchicine must exert an additional effect. Therefore, colchicine not only disrupts the cytoskeleton but may also directly inhibit the Ca L channels.
Because colchicine also stimulates A-cyclase activity by disruption of the microtubules (21) , it should increase cAMP level. Ousterhout and Sperelakis (19) reported that inhibition of Ca L channels and depression of membrane excitability may be important factors in the relaxation of aortic smooth muscle produced by agents that increase intracellular levels of the cyclic Fig. 7 . Effect of nocodazole. A: immunofluorescence staining for smooth muscle anti-␣-actin filaments and anti-␣-tubulin in A7r5 cells treated with nocodazole (1.3 M for 1 h). As can be seen, nocodazole disrupted the microtubules, but not the actin filaments. B: effect of nocodazole (disrupter of microtubules) on I Ba(L) . I-V relationships were obtained for control (E, n ϭ 18) and after exposure to 1.3 M nocodazole (•, n ϭ 16). Please note that the data shown here were obtained in a separate study from those given in Table 3 . Data are expressed as means Ϯ SE. As shown, there was no effect of nocodazole on I Ba(L) . Inset: current traces for control and after application of nocodazole (1.3 M). Cell capacitances were 40 pA (control cell) and 50 pA (nocodazole-treated cell). nucleotides cAMP and cGMP. Xiong et al. (35) showed that intracellular application of PKA (catalytic subunit) caused marked inhibition of I Ca(L) . Ruiz-Velasco et al. (23) reported that cAMP/PKA stimulation (low) enhanced, whereas high elevation and cGMP/cGMPdependent protein kinase (PKG) stimulation inhibited Ca L channel activity in rabbit portal vein myocytes. We recently also showed that low elevation of cAMP actually stimulated I Ca(L) (29, 37) . When PKG is added to the patch pipette for diffusion into the cell during whole cell voltage clamp, basal I Ca is inhibited markedly (and rapidly) in both embryonic chick ventricular cells (11) and in early neonatal rat ventricular myocytes (27) . These findings indicate that the inhibitory effects of cGMP on I Ca are mediated by activation of PKG and resultant phosphorylation, and that the basal I Ca is inhibited (26) . Even though an increase in cAMP might occur due to disruption of microtubules by colchicine, the contribution of this pathway to colchicine inhibition of I Ba(L) must be small because the colchicine inhibition of I Ba(L) was about the same in the presence of phalloidin (only microtubule disruption) and in phalloidin plus taxol (no disruption). The lack of involvement of the cAMP/PKA pathway is also supported from the fact that nocodazole (which disrupted the microtubules, and thereby should stimulate the A-cyclase) did not inhibit Ca L channel activity (Fig. 5) . Perhaps the association between A-cyclase and microtubules may be absent in cultured cells.
In conclusion, actin filament disruption of VSM cells inhibits Ca L channel activity, whereas disrupting the microtubules does not. Nonreceptor Tyr-PK, which is located on the actin-binding protein linking the ion channel to the actin filament, would be displaced from the cytoplasmic face of the plasma membrane by the disruption of the actin filaments. Therefore, actin-filament disruption may interfere with phosphorylation of the Ca L channel by Tyr-PK, thereby removing a basal stimulatory pathway. Alternately, the linking of the ion channel to the actin cytoskeleton by means of a linking protein acts to tether the channel in place, which somehow modulates basal activity of the channel and its regulation (31) .
